Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease

• Main Authors: Yudi Her Oktaviono, Novia Kusumawardhani
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Indonesian Society of Internal Medicine 2020
• Subjects: R Medicine (General); RC666-701 Diseases of the circulatory (Cardiovascular) system
• Online Access: http://repository.unair.ac.id/96335/1/Hyperkalemia%20Associated%20with%20Angiotensin%20Converting%20Enzyme%20Inhibitor%20or%20Angiostensin%20Receptor%20Blockers%20in%20Chronic%20Kidney%20Disease.pdf; http://repository.unair.ac.id/96335/2/Hyperkalemia%20Associated.pdf; http://repository.unair.ac.id/96335/3/Hyperkalemia%20Associated%20with%20Angiotensin%20Converting%20Enzyme%20Inhibitor%20or%20Angiostensin%20Receptor%20Blockers%20in%20Chronic%20Kidney%20Disease.pdf; http://repository.unair.ac.id/96335/; http://www.actamedindones.org/index.php/ijim/article/view/1022
• Institution: Universitas Airlangga

Inhibition of the renin-angiotensin-aldosterone system (RAAS) is a key strategy in treating hypertension in cardiovascular and renal diseases. However, RAAS inhibitors (angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, aldosterone receptor antagonists, and direct renin inhibit...